Home
About the program
Awards
Essential Info
Submit a Proposal
Contact Us

About the program

In 2012, Bayer launched the Global Ophthalmology Awards Program (GOAP) with the aim of advancing the scientific understanding and clinical management of retinal ophthalmic disorders. Through grants supporting research and training in ophthalmology, the program seeks to provide opportunities for treatment improvement and to encourage ophthalmologists to further develop their skills in the management of retinal disorders.

 Who Are We?

The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer, a subgroup of Bayer AG with annual sales of EUR 46.8 billion (2016), is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer aims to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer has a global workforce of 115,200 employees (Dec 31, 2016) and is represented in more than 100 countries.

Bayer envisions the GOAP as a step towards making the dream of ophthalmology cures and improved treatments a reality.

The GOAP demonstrates our commitment to the global ophthalmic disorders community and to advancing state-of-the-art ophthalmic care.
Want to apply for the Global Ophthalmology Awards Program?
©2018 Bayer. All rights reserved.
General Conditions of Use | Privacy Statement | Imprint
 

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Bayer plc.
Tel.: 0118 2063500, Fax.: 0118 2063703, Email: pvuk@bayer.com.